Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Stem cell therapy for ischemic heart disease
Mohammad Nurulqadr Jameel
, Jianyi J Zhang
Medicine - Cardiology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Stem cell therapy for ischemic heart disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Stem Cell Therapy
100%
Myocardium
100%
Ischemic Heart Disease
100%
Stem Cell Transplantation
66%
Bone Marrow Cells
66%
Induced Pluripotent Stem Cells (iPSCs)
33%
Treatment Options
33%
Multipotent Stem Cells
33%
Signaling Pathway
33%
Stem Cells
33%
Cardiomyocytes
33%
Post-infarction
33%
Engraftment
33%
Apoptosis
33%
Bioenergetics
33%
Cardiac Progenitor Cells
33%
Cell Transplantation
33%
Left Ventricular Remodeling
33%
Gene Expression Changes
33%
Beneficial Effects
33%
Poor Differentiation
33%
Neovascularization
33%
Paracrine Effect
33%
Long-term Gene Expression
33%
Preclinical Large Animal Model
33%
Novel Treatments
33%
Medicine and Dentistry
Stem Cell Therapy
100%
Ischemic Heart Disease
100%
Myocardium
100%
Progenitor Cell
66%
Induced Pluripotent Stem Cell
33%
Engraftment
33%
Cell Signaling Pathway
33%
Programmed Cell Death
33%
Gene Expression
33%
Cell Transplantation
33%
Stem Cell
33%
Heart Ventricle Remodeling
33%
Excitement
33%
Cardiac Muscle Cell
33%
Bone Marrow Cell
33%
Treatment Option
33%
Biochemistry, Genetics and Molecular Biology
Stem Cell Transplantation
100%
Progenitor Cell
66%
Animal Models
33%
Cell Excitability
33%
Induced Pluripotent Stem Cell
33%
Stem Cell
33%
Gene Expression
33%
Cell Transplantation
33%
Neovascularization (Pathology)
33%
Bioenergetics
33%
Cardiac Muscle Cell
33%
Programmed Cell Death
33%
Immunology and Microbiology
Stem Cell Transplantation
100%
Engraftment
33%
Bone Marrow Cell
33%
Cell Transplantation
33%
Stem Cell
33%
Gene Expression
33%
Induced Pluripotent Stem Cell
33%
Neovascularization (Pathology)
33%
Excitement
33%
Cardiac Muscle Cell
33%
Programmed Cell Death
33%